Home
/
Zomedica Corp.
/
Financials
/
Quarterly
Zomedica Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Zomedica Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.10M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$6.96M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$6.50M
May 15, 2025
Q3
2025
Sep 30, 2024
$7.00M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$6.13M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$6.26M
May 15, 2025
Q1
2024
Dec 31, 2023
$5.48M
May 9, 2024
Q3
2024
Sep 30, 2023
$6.35M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$6.02M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$5.48M
May 9, 2024
Q3
2023
Sep 30, 2022
$4.78M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$4.25M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$3.75M
May 11, 2023
Q3
2022
Sep 30, 2021
$23.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$16.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$14.0K
May 10, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.12M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($7.40M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($63.81M)
May 15, 2025
Q3
2025
Sep 30, 2024
($6.70M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($23.93M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($9.16M)
May 15, 2025
Q1
2024
Dec 31, 2023
($6.39M)
May 9, 2024
Q3
2024
Sep 30, 2023
($491.0K)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($5.25M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($6.39M)
May 9, 2024
Q3
2023
Sep 30, 2022
($5.00M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($5.27M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($3.94M)
May 11, 2023
Q3
2022
Sep 30, 2021
($6.35M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($4.71M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($4.04M)
May 10, 2022
Q3
2021
Sep 30, 2020
($4.98M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($5.31M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($2.45M)
May 12, 2021
Q3
2020
Sep 30, 2019
($2.85M)
Nov 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.61M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($8.04M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($64.55M)
May 15, 2025
Q3
2025
Sep 30, 2024
($7.44M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($25.07M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($10.39M)
May 15, 2025
Q1
2024
Dec 31, 2023
($7.51M)
May 9, 2024
Q3
2024
Sep 30, 2023
($5.95M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($6.74M)
Aug 14, 2024
Q1
2023
Mar 31, 2023
($7.51M)
May 11, 2023
Q3
2023
Sep 30, 2022
($6.59M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($5.88M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($4.31M)
May 11, 2023
Q3
2022
Sep 30, 2021
($6.41M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.33M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.87M)
May 10, 2022
Q3
2021
Sep 30, 2020
($5.00M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($5.30M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($2.33M)
May 12, 2021
Q3
2020
Sep 30, 2019
($2.84M)
Nov 12, 2020